Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a ...

For patients who have pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), treatment with levosimendan (Simdax; Tenax Therapeutics) can improve both pulmonary ...

Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Experience with terlipressin (TP) in the neonatal field is scarce. We describe the effects of TP on pulmonary circulation, studied with echocardiography, in an asphyxiated septic cooled infant with ...

Winter Haven resident Glenda Johns’ battle with heart failure — marked by increasing weakness and frequent hospital stays — is a textbook case of how the condition can consume patients’ lives. “Every ...

The FDA approved sotatercept (Winrevair) for treating pulmonary arterial hypertension (PAH) in adults, Merck announced on Tuesday. A novel activin signaling inhibitor, sotatercept is indicated to ...

Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension. It means that you have high blood pressure in the arteries that go from your heart to your lungs. But it’s different from ...

Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for diagnosing and treating the blood pressure condition. The Spanish company ...

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in the ...